Have you ever wondered how your diet affects your liver? It turns out that what you eat could play a significant role in the development of non-alcoholic fatty liver disease, a condition that can lead to serious health issues. This disease is tricky because it often shows no symptoms until it's advanced, making it hard to treat. A recent review of 18 studies involving over 262,000 people found a strong link between a high Dietary Inflammatory Index (DII)—which measures how much your diet may promote inflammation—and the risk of developing fatty liver disease. Specifically, people with a higher DII were more likely to develop not just fatty liver but also fibrosis, which is the scarring of the liver. For patients, this means that making healthier dietary choices could potentially lower the risk of liver problems. However, it's important to note that while the findings are significant, they don't prove cause and effect. More research is needed to fully understand this relationship. So, if you're concerned about your liver health, consider talking to your healthcare provider about how diet can play a role.
High Dietary Inflammatory Index Linked to Increased NAFLD Risk (OR 1.33, CI 1.23-1.44)Could Your Diet Be Fueling Fatty Liver Disease?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider dietary modifications to reduce NAFLD risk associated with high DII.
This meta-analysis systematically reviewed 18 studies involving 262,468 participants to evaluate the association between the Dietary Inflammatory Index (DII) and non-alcoholic fatty liver disease (NAFLD), as well as its progression to fibrosis. The primary endpoint was the association between DII and NAFLD incidence, which demonstrated a significant correlation with an odds ratio (OR) of 1.33 (95% CI: 1.23-1.44, P < 0.00001). Additionally, the analysis found a significant association between DII and the progression to fibrosis, with an OR of 1.36 (95% CI: 1.20-1.54, P < 0.00001). Subgroup analyses indicated that geographic region and diagnostic criteria contributed to heterogeneity among the studies. Egger's test suggested the presence of publication bias for NAFLD outcomes. No specific safety or adverse events were reported as the study focused on dietary indices rather than pharmacological interventions. Clinically, these findings suggest that a high DII, indicative of a pro-inflammatory diet, is associated with an increased risk of developing NAFLD and its progression to fibrosis. These results underscore the importance of dietary modifications in managing and potentially preventing NAFLD.
What this means for you:
Eating an anti-inflammatory diet may help protect your liver from serious disease. More on Non-Alcoholic Fatty Liver Disease
General obesity, central obesity, and high triglycerides increase risk of precancerous polyps in colorectal cancer surveillance
Metabolic health matters for colon cancer risk in high-risk surveillance patients
This meta-analysis of 24 observational studies found that metabolic factors such as general obesity, central obesity, hypertension, and high…
Metabolic issues like obesity and diabetes raise the risk of precancerous polyps in people at higher risk for colon cancer. This analysis of…
Higher TyG Index Linked to 4.36-Fold Increased Odds of NAFLD in Large Meta-Analysis
TyG Index Linked to Higher Fatty Liver Risk
This systematic review and meta-analysis of 212,618 participants from observational studies found that higher TyG index levels were associat…
A large analysis found that higher TyG index levels are tied to increased odds of non-alcoholic fatty liver disease. This simple blood test …
Systematic Review: Flavonoids from Traditional Chinese Medicine Show Promise for NAFLD
Flavonoids from Chinese medicine show promise for fatty liver disease
This systematic review examines flavonoids from traditional Chinese medicine for non-alcoholic fatty liver disease. The authors report that …
A systematic review suggests flavonoids from traditional Chinese medicine may improve liver health in humans and animals by reducing fat and…
Narrative review of palmitoleic acid links to metabolic health and fatty liver outcomes
Palmitoleic Acid Shows Mixed Links to Metabolic Health
This narrative review examines palmitoleic acid (POA) supplementation and food matrices regarding insulin resistance, fatty liver, and hyper…
Higher palmitoleic acid levels are tied to fatty liver and insulin resistance, but supplements show neutral effects.
View Original Abstract ↓
BACKGROUND: The Dietary Inflammatory Index (DII) is a literature-based tool designed to predict inflammation. Previous studies suggest a potential association between the DII and non-alcoholic fatty liver disease (NAFLD). However, the relationship between the DII and both the incidence and progression of NAFLD remains unclear.
METHODS: Systematic literature searches were conducted in PubMed, Web of Science, Embase, Scopus, and the Cochrane Library up to July 2025. A random-effects model was applied, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Sensitivity and subgroup analyses were performed to explore the sources of heterogeneity, while Egger's test was used to assess publication bias. Review Manager 5.4 and STATA 15.0 were employed for statistical analysis.
RESULTS: Eighteen studies involving 262,468 participants were included. The data indicated a significant association between the DII and NAFLD (OR = 1.33, 95% CI: 1.23-1.44; P < 0.00001) and between the DII and fibrosis (OR = 1.36, 95% CI: 1.20-1.54; P < 0.00001). Subgroup analysis identified geographic region and diagnostic criteria as sources of heterogeneity. Egger's test revealed publication bias for NAFLD.
CONCLUSION: A high DII was associated with an increased risk of NAFLD and an increased risk of progression to fibrosis.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42025632168.
Higher TyG Index Linked to 4.36-Fold Increased Odds of NAFLD in Large Meta-Analysis
TyG Index Linked to Higher Fatty Liver Risk
Related in Gastroenterology
Acupuncture modulates the microbiota-gut-brain axis to remodel microbial structure in patients with irritable bowel syndrome
Acupuncture May Help Manage Irritable Bowel Syndrome Symptoms
This systematic review examines how acupuncture influences the microbiota-gut-brain axis in patients with irritable bowel syndrome. The auth…
New research suggests acupuncture may help manage irritable bowel syndrome by improving gut bacteria and balancing the gut-brain connection.
Reduced Shannon index indicates lower alpha-diversity in the gut microbiota of patients with primary biliary cholangitis
Gut Microbiota Differences Linked to Primary Biliary Cholangitis
This meta-analysis of 1,057 participants found that patients with primary biliary cholangitis have significantly lower Shannon index values …
A large review of patient data shows that people with primary biliary cholangitis have significantly lower gut bacterial diversity than heal…
Probiotic supplementation may improve salivary buffering and reduce cariogenic bacteria
A review of six studies shows probiotics may help oral and gut health in people
This systematic review of 6 reviews suggests probiotic supplementation may improve salivary buffering capacity and plaque pH, reduce Strepto…
This review looked at six studies on probiotic supplements. Results suggest better saliva function and fewer bad mouth bacteria, though stud…
Balloon-assisted ESD shows comparable outcomes to conventional ESD for colorectal polyps
Balloon-assisted endoscopic submucosal dissection shows shorter procedure time in RCTs
This systematic review and meta-analysis of 1449 patients found that balloon-assisted endoscopic submucosal dissection (BA-ESD) and conventi…
A meta-analysis of 1,449 patients found balloon-assisted endoscopic submucosal dissection had shorter procedure times in randomized trials, …
From Other Specialties
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.